Early doxycycline use may raise pregnancy loss risk
MDSpire News
November 10, 2026
You now have access to the trusted editorial news and specialty content you've known from the Conexiant news site—all within the MDSpire experience.
Learn more

This retrospective cohort study analyzed 218,234 pregnancies with respiratory tract infections and 6,636 pregnancies with acne in US claims databases.
For respiratory tract infections, first-trimester doxycycline exposure was associated with higher adjusted relative risks of pregnancy loss than amoxicillin or macrolides in both databases.
For acne, doxycycline was associated with higher pregnancy loss risk than topical clindamycin in MarketScan, but not in Medicaid.
Sensitivity analyses generally supported the respiratory tract infection findings, while stillbirth-specific results were inconclusive because of few events.
The observational study could not establish causality and was limited by possible exposure misclassification, missed early losses, and residual confounding.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Affiliations:
Specialties:
Areas of Expertise: